Detalles de la búsqueda
1.
Osimertinib: A third-generation tyrosine kinase inhibitor for treatment of epidermal growth factor receptor-mutated non-small cell lung cancer with the acquired Thr790Met mutation.
J Oncol Pharm Pract;
24(5): 379-388, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28565936
2.
Synthesis and characterization of DNA minor groove binding alkylating agents.
Chem Res Toxicol;
26(1): 156-68, 2013 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-23234400
3.
Immune-Related Adverse Events in PD-1 Treated Melanoma and Impact Upon Anti-Tumor Efficacy: A Real World Analysis.
Front Oncol;
11: 749064, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34900695
4.
Vancomycin-resistant enterococci in acute myeloid leukemia and myelodysplastic syndrome patients undergoing induction chemotherapy with idarubicin and cytarabine.
Leuk Lymphoma;
58(11): 2565-2572, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28351179
5.
Multikinase Inhibitors Induce Cutaneous Toxicity through OAT6-Mediated Uptake and MAP3K7-Driven Cell Death.
Cancer Res;
76(1): 117-26, 2016 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26677977
6.
Phase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractory leukemia.
J Clin Oncol;
29(24): 3293-300, 2011 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21768474
Resultados
1 -
6
de 6
1
Próxima >
>>